GenfitAct. Aktie
4,01EUR | -0,01EUR | -0,25% |
WKN DE: A0LGJ2 / ISIN: FR0004163111
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 86,63 |
Ipsen SA | 7,98 |
Tang Capital Management LLC | 4,91 |
Biotech Avenir SAS | 3,78 |
Universite de Lille II Foundation | 1,30 |
HealthInvest Small & Micro Cap Fund | 1,14 |
GS Funds - Global Small Cap Core Equity Portfolio | 0,64 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 194 | 130 | 122 | 148 | 159 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,16 | 0,01 | 0,66 | 0,14 | 0,18 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 291 | 185 | 268 | 158 | 113 |
Summe Anlagevermögen | 19 | 13 | 13 | 57 | 60 |
Summe Aktiva | 310 | 198 | 281 | 215 | 173 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 184 | 186 | 74 | 75 | 70 |
Summe Fremdkapital | 226 | 215 | 163 | 121 | 106 |
Summe Eigenkapital | 84 | -17 | 119 | 94 | 67 |
Summe Passiva | 310 | 198 | 281 | 215 | 173 |
Adresse
Parc Eurasante, 59120 Loos | |
Telefon | +33 (3) 20-16-40-00 |
Fax | +33 (3) 20-16-40-01 |
Internet | http://www.genfit.com |
Management
Anne-Hélène Monsellato
Independent Director |
Carol L. Addy
Chief Medical Officer |
Catherine Larue
Independent Director |
Dean W. Hum
Chief Scientific Officer |
Eric Baclet
Vice Chairman |
Florence Séjourné
Director |
Jean-Christophe Marcoux
Chief Corporate Affairs Officer |
Jean-François Mouney
Chairman |
Jean-François Tiné
Independent Director |
John Brozek
Vice President-Data & Information Technology |
Katherine Bach Kalin
Independent Director |
Laurent Lannoo
Secretary & Director-Legal Affairs |
Meriam Kabbaj
Chief Technology Officer |
Pascal Caisey
Chief Operating Officer |
Pascal Prigent
Chief Executive Officer |
Sandra Silvestri
Director |
Stefanie Magner
Chief Compliance Officer |
Thomas Baetz
Chief Financial Officer |
Tom Huijbers
Executive Vice President-Regulatory Affairs |
Émilie Desodt
Executive Vice President-Human Resources |